These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23016837)

  • 21. Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.
    Edwards ER; Spira AP; Barnes DE; Yaffe K
    Int J Geriatr Psychiatry; 2009 Jul; 24(7):716-22. PubMed ID: 19140134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment.
    Lee YG; Park M; Jeong SH; Baik K; Kang S; Yoon SH; Na HK; Sohn YH; Lee PH
    Neurology; 2023 Sep; 101(12):e1186-e1195. PubMed ID: 37524535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond the "C" in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment.
    Ellison JM; Harper DG; Berlow Y; Zeranski L
    CNS Spectr; 2008 Jan; 13(1):66-72. PubMed ID: 18204416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study.
    Montero-Odasso MM; Sarquis-Adamson Y; Speechley M; Borrie MJ; Hachinski VC; Wells J; Riccio PM; Schapira M; Sejdic E; Camicioli RM; Bartha R; McIlroy WE; Muir-Hunter S
    JAMA Neurol; 2017 Jul; 74(7):857-865. PubMed ID: 28505243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MCI subtype and reversion on progression to dementia in a community sample.
    Aerts L; Heffernan M; Kochan NA; Crawford JD; Draper B; Trollor JN; Sachdev PS; Brodaty H
    Neurology; 2017 Jun; 88(23):2225-2232. PubMed ID: 28490651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.
    Pink A; Stokin GB; Bartley MM; Roberts RO; Sochor O; Machulda MM; Krell-Roesch J; Knopman DS; Acosta JI; Christianson TJ; Pankratz VS; Mielke MM; Petersen RC; Geda YE
    Neurology; 2015 Mar; 84(9):935-43. PubMed ID: 25653291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
    Ten Kate M; Barkhof F; Visser PJ; Teunissen CE; Scheltens P; van der Flier WM; Tijms BM
    Alzheimers Res Ther; 2017 Sep; 9(1):73. PubMed ID: 28899429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review.
    Martin E; Velayudhan L
    Dement Geriatr Cogn Disord; 2020; 49(2):146-155. PubMed ID: 32289790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
    Qiu J; Goldstein FC; Hanfelt JJ
    Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms.
    Hwang TJ; Masterman DL; Ortiz F; Fairbanks LA; Cummings JL
    Alzheimer Dis Assoc Disord; 2004; 18(1):17-21. PubMed ID: 15195459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly.
    Xu X; Ang SL; Hilal S; Chan QL; Wong TY; Venketasubramanian N; Ikram MK; Chen CL
    Int Psychogeriatr; 2015 Nov; 27(11):1839-47. PubMed ID: 26201550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.
    Pyun JM; Park YH; Kim HR; Suh J; Kang MJ; Kim BJ; Youn YC; Jang JW; Kim S;
    Alzheimers Res Ther; 2017 Dec; 9(1):99. PubMed ID: 29246250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
    Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
    JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.
    Soysal P; Smith L; Trott M; Alexopoulos P; Barbagallo M; Tan SG; Koyanagi A; Shenkin S; Veronese N;
    Psychogeriatrics; 2022 May; 22(3):402-412. PubMed ID: 35128762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric symptoms as a distinguishing factor between memory diagnoses.
    Rouse HJ; Small BJ; Schinka JA; Hazlett AM; Loewenstein DA; Duara R; Potter H
    Int J Geriatr Psychiatry; 2020 Oct; 35(10):1115-1122. PubMed ID: 32391573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment.
    Sugarman MA; Alosco ML; Tripodis Y; Steinberg EG; Stern RA
    J Alzheimers Dis; 2018; 62(4):1841-1855. PubMed ID: 29614641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease.
    Teng E; Lu PH; Cummings JL
    Dement Geriatr Cogn Disord; 2007; 24(4):253-9. PubMed ID: 17700021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.
    Peters KR; Rockwood K; Black SE; Bouchard R; Gauthier S; Hogan D; Kertesz A; Loy-English I; Beattie BL; Sadovnick AD; Feldman HH
    Neurology; 2006 Feb; 66(4):523-8. PubMed ID: 16505306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment.
    Sachs-Ericsson N; Blazer DG
    Aging Ment Health; 2015 Jan; 19(1):2-12. PubMed ID: 24914889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease.
    Huang MF; Lee WJ; Yeh YC; Lin YS; Lin HF; Wang SJ; Yang YH; Chen CS; Fuh JL
    J Formos Med Assoc; 2022 Sep; 121(9):1705-1713. PubMed ID: 34933801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.